About us Europe South America South Africa NL Globally active in environmental services , renewable energy and real estate . Innovator and investor in niche markets such as Enhanced Landfill Mining (ELFM) and timber frame construction. What and where? Europe ENVIRONMENTAL MANAGEMENT RENEWABLE ENERGY REAL ESTATE CONSTRUCTION South America ENVIRONMENTAL MANAGEMENT RENEWABLE ENERGY REAL ESTATE South Africa 03.11.2021 Bekijk hier de after-movie van het Langerlo evenement (02/10/21) De centrale van Langerlo vormt sinds de jaren ’70 een… LEES MEER 08.10.2021 Limburg als logistieke hotspot: we zijn er klaar voor! https://www.voka.be/nieuws/limburg-als-logistieke-hotspot-we-zijn-er-klaar-voor LEES MEER 08.10.2021 LOGISTIEKE SWEET SPOT Verhaal – Group Machiels – Intervest Offices & Warehouses https://www.sterck-magazine.be/limburg/editie-42/logistieke-sweet-spot-3698/ LEES MEER Map Satellite Keyboard shortcuts Map data ©2021 Terms of Use Report a map error Ekkelgaarden 16 3500 Hasselt t. +32 11 28 70 70 f. +32 11 28 70 51 contact@machiels.com Ekkelgaarden 16 3500 Hasselt t. +32 11 28 70 70 f. +32 11 28 70 51 contact@machiels.com © Group Machiels 2021, Created by hands Contact Disclaimer Privacy Policy Cookie policy ACCEPT Machiels uses cookies for a better web experience. Knowing more?

About us Europe South America South Africa NL Beta-Cell INVESTMENTS Home / Investments / Beta-Cell back to the overview Activity Beta-Cell is a spin-out of the Vrije Universiteit Brussel (VUB) and conducts groundbreaking research into the effective cure of diabetes or diabetes (insulin-dependent type 1). Until now, diabetes can only be treated by administering insulin. Beta-Cell is developing a unique cell therapy with very high potential. This therapy, BetaGraft, can replace lost -cells – the cells that produce insulin – and take over their function. In diabetic patients, pancreatic cell grafts are transplanted that grow into a full-fledged source of biologically regulated insulin production. Because humans have almost no transplant material available for this, the cells are prepared from pig pancreata. BetaGraft yields much better results in preclinical animal models than the transplantation experiments with human cells. The cure for diabetes would be a milestone in the history of medicine. In 2015, there were an estimated 415 million patients with diabetes, the number expected to rise to 640 million by 2040. The technology is currently in the preclinical phase. The first human clinical trials could be rolled out around 2021, so that BetaGraft could hit the market in 2024/2025. Group Machiels has a substantial participation in this promising company of great social benefit. Beta-Cell is located in BioVille, on the university campus in Diepenbeek. VISIT THE WEBSITE watch the video Location Belgium Diepenbeek Europe ENVIRONMENTAL MANAGEMENT RENEWABLE ENERGY REAL ESTATE CONSTRUCTION South America ENVIRONMENTAL MANAGEMENT RENEWABLE ENERGY REAL ESTATE South Africa ACCEPT Machiels uses cookies for a better web experience. Knowing more? © Group Machiels 2021, Created by hands Contact Disclaimer Privacy Policy Cookie policy